Literature DB >> 1641400

Carcinogen-mediated oxidant formation and oxidative DNA damage.

K Frenkel1.   

Abstract

This article reviews the experimental data that points to formation of reactive oxygen species (ROS) and oxidative DNA base damage as being important contributors to cancer development. Particular emphasis is placed on the role they play in genetic changes occurring during tumor promotion. A number of structurally different anticarcinogenic agents inhibit ROS production and oxidative DNA damage as they inhibit inflammation and tumor promotion. This underlines the importance of ROS and oxidative genetic damage to the carcinogenic process. It also points to the possibility that some types of cancer may be preventable if the cycles of tumor promotion can be interrupted.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1641400     DOI: 10.1016/0163-7258(92)90047-4

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  55 in total

1.  Association between XRCC3 Thr241Met polymorphism and nasopharyngeal carcinoma risk: evidence from a large-scale case-control study and a meta-analysis.

Authors:  Qian Cui; Xiao-Yu Zuo; Yi-Fan Lian; Qi-Sheng Feng; Yun-Fei Xia; Cai-Yun He; Li-Zhen Chen; Wei-Hua Jia; Hai-Qiang Mai; Yi-Xin Zeng; Jin-Xin Bei
Journal:  Tumour Biol       Date:  2016-09-17

2.  Measurement of oxidized and methylated DNA bases by HPLC with electrochemical detection.

Authors:  H Kaur; B Halliwell
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

3.  Mapping frequencies of endogenous oxidative damage and the kinetic response to oxidative stress in a region of rat mtDNA.

Authors:  W J Driggers; G P Holmquist; S P LeDoux; G L Wilson
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

4.  Sequence dependent hole evolution in DNA.

Authors:  V D Lakhno
Journal:  J Biol Phys       Date:  2004-06       Impact factor: 1.365

5.  L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation.

Authors:  G Fortin; K Yurchenko; C Collette; M Rubio; A-C Villani; A Bitton; M Sarfati; D Franchimont
Journal:  Clin Exp Immunol       Date:  2009-01-23       Impact factor: 4.330

6.  Photolysis of N-hydroxpyridinethiones: a new source of hydroxyl radicals for the direct damage of cell-free and cellular DNA.

Authors:  B Epe; D Ballmaier; W Adam; G N Grimm; C R Saha-Möller
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

7.  Effect of supplementation with chromium picolinate on antibody titers to 5-hydroxymethyl uracil.

Authors:  I Kato; J H Vogelman; V Dilman; J Karkoszka; K Frenkel; N P Durr; N Orentreich; P Toniolo
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

8.  Physical activity and lung cancer among non-smokers: a pilot molecular epidemiological study within EPIC.

Authors:  Andrew Rundle; John Richie; Karen Steindorf; Marco Peluso; Kim Overvad; Ole Raaschou-Nielsen; Francoise Clavel-Chapelon; Jacob P Linseisen; Heiner Boeing; Antonia Trichopoulou; Domenico Palli; Vittorio Krogh; Rosario Tumino; Salvatore Panico; Hendrik B Bueno-De-Mesquita; Petra H Peeters; Eiliv Lund; Carlos A Gonzalez; Carmen Martinez; Miren Dorronsoro; Aurelio Barricarte; M Jose Tormo; Josèr Quiros; Antonio Agudo; Goran Berglund; Bengt Jarvholm; Sheila Bingham; Timothy J Key; Emmanuelle Gormally; Rodolfo Saracci; Rudolf Kaaks; Elio Riboli; Paolo Vineis
Journal:  Biomarkers       Date:  2010-02       Impact factor: 2.658

9.  Zebrafish as a model system to screen radiation modifiers.

Authors:  Misun Hwang; Cha Yong; Luigi Moretti; Bo Lu
Journal:  Curr Genomics       Date:  2007-09       Impact factor: 2.236

10.  No association between mitochondrial DNA copy number and colorectal adenomas.

Authors:  Bharat Thyagarajan; Weihua Guan; Veronika Fedirko; Helene Barcelo; Huakang Tu; Myron Gross; Michael Goodman; Roberd M Bostick
Journal:  Mol Carcinog       Date:  2015-08-10       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.